CLINICAL_TRIALS
trial_result
· 2024-02-22
Clinical Trial Update: Afimoxifene in Reducing the Risk of Breast Cancer in Women With Mammographically Dense Breast [Phase 2]
Summary
Phase 2 trial evaluating afimoxifene to reduce breast cancer risk in women with mammographically dense breasts has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: M.D. Anderson Cancer Center | Conditions: Mammographically Dense Breast | Phase 2 | Status: COMPLETED | Results posted: 2024-02-22